Genmab (Otc) (GMAB) has released an update.
Genmab A/S has outlined its corporate structure, including share capital provisions, warrant issuance, and convertible debt instruments, with authorizations for board-directed capital increases and detailed terms for shareholder rights. The company, based in Copenhagen, focuses on medical research and product sale, with English as its group language. Share capital can be increased by DKK 6,600,000, with additional warrants and convertible debt instruments potentially expanding capital further, all subject to board approval and market value alignment.
For further insights into GMAB stock, check out TipRanks’ Stock Analysis page.
